Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin M Cates

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The Prostate|July 13, 2022
Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patientsRenjie Jin, Connor Forbes, Nicole L Miller, et al.
American Journal of Respiratory and Critical Care Medicine|December 3, 2016
Secretory IgA Deficiency in Individual Small Airways Is Associated with Persistent Inflammation and RemodelingVasiliy V Polosukhin, Bradley W Richmond, Rui-Hong Du, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2011
Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary diseaseVasiliy V Polosukhin, Justin M Cates, William E Lawson, et al.
Oncotarget|November 29, 2016
Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancerShanna A Arnold Egloff, Liping Du, Holli A Loomans, et al.
Cancer Research|January 9, 2016
EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung CancerKatherine R Amato, Shan Wang, Li Tan, et al.
European Urology|April 16, 2013
A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cellsMohammad Moad, Deepali Pal, Anastasia C Hepburn, et al.
The Journal of Clinical Investigation|April 10, 2014
Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLCKatherine R Amato, Shan Wang, Andrew K Hastings, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 21, 2014
FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotypeDavid J DeGraff, Magdalena M Grabowska, Tom C Case, et al.
Endocrinology|December 19, 2015
Nfib Regulates Transcriptional Networks That Control the Development of Prostatic HyperplasiaMagdalena M Grabowska, Stephen M Kelly, Amy L Reese, et al.
Plos One|May 17, 2012
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferationDavid J DeGraff, Peter E Clark, Justin M Cates, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Prostate|July 13, 2022
Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patientsRenjie Jin, Connor Forbes, Nicole L Miller, et al.
American Journal of Respiratory and Critical Care Medicine|December 3, 2016
Secretory IgA Deficiency in Individual Small Airways Is Associated with Persistent Inflammation and RemodelingVasiliy V Polosukhin, Bradley W Richmond, Rui-Hong Du, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2011
Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary diseaseVasiliy V Polosukhin, Justin M Cates, William E Lawson, et al.
Oncotarget|November 29, 2016
Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancerShanna A Arnold Egloff, Liping Du, Holli A Loomans, et al.
Cancer Research|January 9, 2016
EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung CancerKatherine R Amato, Shan Wang, Li Tan, et al.
European Urology|April 16, 2013
A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cellsMohammad Moad, Deepali Pal, Anastasia C Hepburn, et al.
The Journal of Clinical Investigation|April 10, 2014
Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLCKatherine R Amato, Shan Wang, Andrew K Hastings, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 21, 2014
FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotypeDavid J DeGraff, Magdalena M Grabowska, Tom C Case, et al.
Endocrinology|December 19, 2015
Nfib Regulates Transcriptional Networks That Control the Development of Prostatic HyperplasiaMagdalena M Grabowska, Stephen M Kelly, Amy L Reese, et al.
Plos One|May 17, 2012
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferationDavid J DeGraff, Peter E Clark, Justin M Cates, et al.
Pageof 4